Abstract:OBJECTIVES:The streptozotocin (STZ) model is widely used in diabetes research. However, the cellular and molecular states of pancreatic endocrine cells in this model remain unclear. This study explored the molecular characteristics of islet cells treated with STZ and re-evaluated β-cell dysfunction and regeneration in the STZ model. METHODS:We performed single-cell RNA sequencing of pancreatic endocrine cells from STZ-treated mice. High-quality sequencing data from 2,999 cells were used to identify clusters via Louvain clustering analysis. Principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), uniform manifold approximation and projection (UMAP), force-directed layout (FDL), and differential expression analysis were used to define the heterogeneity and transcriptomic changes in islet cells. In addition, qPCR and immunofluorescence staining were used to confirm findings from the sequencing data. RESULTS:Untreated β-cells were divided into two populations at the transcriptomic level, a large high-Glut2 expression (Glut2high) population and a small low-Glut2 expression (Glut2low) population. At the transcriptomic level, Glut2low β-cells in adult mice did not represent a developmentally immature state, although a fraction of genes associated with β-cell maturation and function were downregulated in Glut2low cells. After a single high-dose STZ treatment, most Glut2high cells were killed, but Glut2low cells survived and over time changed to a distinct cell state. We did not observe conversion of Glut2low to Glut2high β-cells up to 9 months after STZ treatment. In addition, we did not detect transcriptomic changes in the non-β endocrine cells or a direct trans-differentiation pathway from the α-cell lineage to the β-cell lineage in the STZ model. CONCLUSIONS:We identified the heterogeneity of β-cells in both physiological and pathological conditions. However, we did not observe conversion of Glut2low to Glut2high β-cells, transcriptomic changes in the non-β endocrine cells, or direct trans-differentiation from the α-cell lineage to the β-cell lineage in the STZ model. Our results clearly define the states of islet cells treated with STZ and allow us to re-evaluate the STZ model widely used in diabetes studies.

ZnT8 Loss-of-function Accelerates Functional Maturation of Hesc-Derived Β Cells and Resists Metabolic Stress in Diabetes

In Vivo Targeted Delivery of ANGPTL8 Gene for Beta Cell Regeneration in Rats

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Pancreatic β cell–selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis

Targeted Pharmacological Therapy Restores Beta-Cell Function For Diabetes Remission

Mitofusin2 Promotes Β Cell Maturation from Mouse Embryonic Stem Cells Via Sirt3/Idh2 Activation

Beta cell specific ZnT8 gene deficiency and resulting loss in zinc content significantly improve insulin secretion

Lack of ZnT8 protects pancreatic islets from hypoxia- and cytokine-induced cell death

Comments on ‘dietary Intervention Preserves Β Cell Function in Mice Through CTCF-mediated Transcriptional Reprogramming’

Restoration of PKM1 improves functional maturation of human stem-cell derived-β cell by regulating PEP metabolism

Limitations in mitochondrial programming restrain the differentiation and maturation of human stem cell-derived β cells

Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency

LINC MIR503HG Controls SC‐β Cell Differentiation and Insulin Production by Targeting CDH1 and HES1

Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice

SNP alleviates mitochondrial homeostasis dysregulation-mediated developmental toxicity in diabetic zebrafish larvae

A δ-cell subpopulation with a pro-β-cell identity confers efficient age-independent recovery in a zebrafish model of diabetes

Reversibility Ofβ-Cell-specific Transcript Factors Expression by Long-Term Caloric Restriction in Db/db Mouse

286-OR: Using iPSC-Derived Islets to Model the Effect of an ABCC8 Arg1420His Mutation in Fetal and Adult Islets

EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors

Characterizing Pancreatic Β-Cell Heterogeneity in the Streptozotocin Model by Single-Cell Transcriptomic Analysis.